SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-20-002568
Filing Date
2020-02-28
Accepted
2020-02-28 16:09:23
Documents
102
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptla-20191231x10k.htm   iXBRL 10-K 2980885
2 EX-4.2 ptla-20191231xex42.htm EX-4.2 23125
3 EX-23.1 ptla-20191231xex231.htm EX-23.1 2801
4 EX-31.1 ptla-20191231xex311.htm EX-31.1 8677
5 EX-31.2 ptla-20191231xex312.htm EX-31.2 8711
6 EX-32.1 ptla-20191231xex321.htm EX-32.1 7141
12 GRAPHIC a201910kperformancegraph.jpg GRAPHIC 59629
  Complete submission text file 0001628280-20-002568.txt   13460819

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptla-20191231.xsd EX-101.SCH 90701
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptla-20191231_cal.xml EX-101.CAL 119328
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptla-20191231_def.xml EX-101.DEF 494100
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptla-20191231_lab.xml EX-101.LAB 1146110
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptla-20191231_pre.xml EX-101.PRE 729099
50 EXTRACTED XBRL INSTANCE DOCUMENT ptla-20191231x10k_htm.xml XML 2433780
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35935 | Film No.: 20670113
SIC: 2834 Pharmaceutical Preparations